Harold Marcotte

About me
Publications
CV
Public outreach and news

About me

I am currently a researcher and a docent in the Division of Immunology within the Department of Medical Biochemistry and Biophysics (MBB). My primary research focus is to establish passive immunotherapy against mucosal infectious diseases and studying host-microbe interactions. My work includes the development and engineering of human monoclonal and camelid antibodies against coronaviruses, Helicobacter pylori, and noroviruses. I am also investigating the use of recombinant Lactobacillus as a delivery system for antibodies at mucosal surfaces. More recently, I have been conducting research on the systemic and mucosal immune response to SARS-CoV-2 in vaccinated and infected individuals..

Teaching

I am teaching immunology for the Biomedicine Laboratory Science program (Biomedicinska analytikerprogrammet).

Articles

Article: GENES AND IMMUNITY. 2024;25(2):158-167
Comparative single-cell transcriptomic profile of hybrid immunity induced by adenovirus vector-based COVID-19 vaccines
Garcia-Vega M; Wan H; Resendiz-Sandoval M; Hinojosa-Trujillo D; Valenzuela O; Mata-Haro V; Dehesa-Canseco F; Solis-Hernandez M; Marcotte H; Pan-Hammarstrom Q; Hernandez J
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2024;121(3):e2315354120
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents Infection of Omicron lineages
Marcotte H; Cao Y; Zuo F; Simonelli L; Sammartino JC; Pedotti M; Sun R; Cassaniti I; Hagbom M; Piralla A; Yang J; Du L; Percivalle E; Bertoglio F; Schubert M; Abolhassani H; Sherina N; Guerra C; Borte S; Rezaei N; Kumagai-Braesch M; Xue Y; Su C; Yan Q; He P; Groenwall C; Klareskog L; Calzolai L; Cavalli A; Wang Q; Robbiani DF; Hust M; Shi Z; Feng L; Svensson L; Chen L; Bao L; Baldanti F; Xiao J; Qin C; Hammarstrom L; Yang X; Varani L; Xie XS; Pan-Hammarstrom Q
Article: NATURE COMMUNICATIONS. 2023;14(1):6527
Design, structure and plasma binding of ancestral β-CoV scaffold antigens
Hueting D; Schriever K; Sun R; Vlachiotis S; Zuo F; Du L; Persson H; Hofstrom C; Ohlin M; Wallden K; Buggert M; Hammarstrom L; Marcotte H; Pan-Hammarstroem Q; Andrell J; Syren P-O
Article: ISCIENCE. 2023;26(4):106562
19n01, a broadly neutralizing antibody against omicron BA.1, BA.2, BA.4/5, and other SARS-CoV-2 variants of concern
Garcia-Vega M; Melgoza-Gonzalez EA; Hernandez-Valenzuela S; Hinojosa-Trujillo D; Resendiz-Sandoval M; Llamas-Covarrubias MA; Loza-Lopez M; Valenzuela O; Soto-Gaxiola A; Hernandez-Onate MA; Mata-Haro V; Cassaniti I; Sammartino JC; Ferrari A; Simonelli L; Pedotti M; Sun R; Zuo F; Baldanti F; Varani L; Marcotte H; Pan-Hammarstrom Q; Hernandez J
Article: SCIENCE IMMUNOLOGY. 2023;8(81):eade0958
Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein
Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Rincon TC; Fava T; Podesvova L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Honig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Clabbattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarstroem Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
Article: PHARMACEUTICS. 2022;15(1):63
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Yuki Y; Zuo F; Kurokawa S; Uchida Y; Sato S; Sakon N; Hammarstroem L; Kiyono H; Marcotte H
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;150(5):1059-1073
Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19
Abolhassani H; Delavari S; Landegren N; Shokri S; Bastard P; Du L; Zuo F; Hajebi R; Abolnezhadian F; Iranparast S; Modaresi M; Vosughimotlagh A; Salami F; Aranda-Guillen M; Cobat A; Marcotte H; Zhang S-Y; Zhang Q; Rezaei N; Casanova J-L; Kampe O; Hammarstrom L; Pan-Hammarstrom Q
Article: NATURE COMMUNICATIONS. 2022;13(1):2670
Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant
Zuo F; Abolhassani H; Du L; Piralla A; Bertoglio F; de Campos-Mata L; Wan H; Schubert M; Cassaniti I; Wang Y; Sammartino JC; Sun R; Vlachiotis S; Bergami F; Kumagai-Braesch M; Andrell J; Zhang Z; Xue Y; Wenzel EV; Calzolai L; Varani L; Rezaei N; Chavoshzadeh Z; Baldanti F; Hust M; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2022;42(3):471-483
Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
Abolhassani H; Landegren N; Bastard P; Materna M; Modaresi M; Du L; Aranda-Guillen M; Sardh F; Zuo F; Zhang P; Marcotte H; Marr N; Khan T; Ata M; Al-Ali F; Pescarmona R; Belot A; Beziat V; Zhang Q; Casanova J-L; Kampe O; Zhang S-Y; Hammarstrom L; Pan-Hammarstrom Q
Article: BMC MEDICINE. 2022;20(1):102
Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Schubert M; Bertoglio F; Steinke S; Heine PA; Ynga-Durand MA; Maass H; Sammartino JC; Cassaniti I; Zuo F; Du L; Korn J; Milosevic M; Wenzel EV; Krstanovic F; Polten S; Pribanic-Matesic M; Brizic I; Baldanti F; Hammarstrom L; Duebel S; Sustic A; Marcotte H; Strengert M; Protic A; Piralla A; Pan-Hammarstroem Q; Cicin-Sain L; Hust M
Article: ISCIENCE. 2022;25(2):103743
Immunity to SARS-CoV-2 up to 15 months after infection
Marcotte H; Piralla A; Zuo F; Du L; Cassaniti I; Wan H; Kumagai-Braesh M; Andrell J; Percivalle E; Sammartino JC; Wang Y; Vlachiotis S; Attevall J; Bergami F; Ferrari A; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Asperges E; Bruno R; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Calzolai L; Varani L; Hust M; Xue Y; Hammarstrom L; Baldanti F; Pan-Hammarstrom Q
Article: JOURNAL OF CLINICAL IMMUNOLOGY. 2022;42(1):1-9
X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
Abolhassani H; Vosughimotlagh A; Asano T; Landegren N; Boisson B; Delavari S; Bastard P; Aranda-Guillen M; Wang Y; Zuo F; Sardh F; Marcotte H; Du L; Zhang S-Y; Zhang Q; Rezaei N; Kampe O; Casanova J-L; Hammarstrom L; Pan-Hammarstrom Q
Article: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022;149(1):65-75.e8
SARS-CoV-2-specific B- and T-cell immunity in a population-based study of young Swedish adults
Bjorkander S; Du L; Zuo F; Ekstrom S; Wang Y; Wan H; Sherina N; Schoutens L; Andrell J; Andersson N; Georgelis A; Bergstrom A; Marcotte H; Kull I; Hammarstrom L; Melen E; Pan-Hammarstrom Q
Article: MED. 2021;2(3):281-295.e4
Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6-8 months after the infection
Sherina N; Piralla A; Du L; Wan H; Kumagai-Braesch M; Andrell J; Braesch-Andersen S; Cassaniti I; Percivalle E; Sarasini A; Bergami F; Di Martino R; Colaneri M; Vecchia M; Sambo M; Zuccaro V; Bruno R; Sachs M; Oggionni T; Meloni F; Abolhassani H; Bertoglio F; Schubert M; Byrne-Steele M; Han J; Hust M; Xue Y; Hammarstrom L; Baldanti F; Marcotte H; Pan-Hammarstrom Q
Article: VACCINES. 2020;8(4):E758-758
Lactobacilli Expressing Broadly Neutralizing Nanobodies against HIV-1 as Potential Vectors for HIV-1 Prophylaxis?
Kalusche S; Vanshylla K; Kleipass F; Gruell H; Muller B; Zeng Z; Koch K; Stein S; Marcotte H; Klein F; Dietrich U
Article: JOURNAL OF INFECTIOUS DISEASES. 2020;222(3):470-478
A Heterodimeric Antibody Fragment for Passive Immunotherapy Against Norovirus Infection
Yuki Y; Kurokawa S; Sato S; Sasou A; Matsumoto N; Suzuki A; Sakon N; Goda Y; Takeyama N; Miyoshi T; Marcotte H; Tanaka T; Hammarstrom L; Kiyono H
Article: CLINICAL GENETICS. 2020;97(6):844-856
Clinical implications of experimental analyses of AID function on predictive computational tools: Challenge of missense variants
Abolhassani H; Marcotte H; Fang M; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2019;85(19):e00800-e00819
Putative Adhesion Factors in Vaginal Lactobacillus gasseri DSM 14869: Functional Characterization
Zeng Z; Zu F; Marcotte H
Article: BMC INFECTIOUS DISEASES. 2019;19(1):824
An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis
Marcotte H; Larsson PG; Andersen KK; Zuo F; Mikkelsen LS; Brandsborg E; Gray G; Laher F; Otwombe K
Article: ACS SYNTHETIC BIOLOGY. 2019;8(8):1723-1729
Inducible Plasmid Self-Destruction (IPSD) Assisted Genome Engineering in Lactobacilli and Bifidobacteria
Zuo F; Zeng Z; Hammarstrom L; Marcotte H
Article: MICROBIOLOGICAL RESEARCH. 2017;205:88-98
Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L-gasseri DSM 14869 contained in the EcoVag® probiotic vaginal capsules
Marcotte H; Andersen KK; Lin Y; Zuo F; Zeng Z; Larsson PG; Brandsborg E; Bronstad G; Hammarstrom L
Article: MICROBIAL CELL FACTORIES. 2017;16(1):148
Lactobacillus delivery of bioactive interleukin-22
Lin Y; Krogh-Andersen K; Hammarstrom L; Marcotte H
Article: SCIENTIFIC REPORTS. 2016;6:30171
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus
Gunaydin G; Yu S; Graslund T; Hammarstrom L; Marcotte H
Article: INFECTION AND IMMUNITY. 2016;84(2):395-406
Neutralization of Clostridium difficile Toxin B Mediated by Engineered Lactobacilli That Produce Single-Domain Antibodies
Andersen KK; Strokappe NM; Hultberg A; Truusalu K; Smidt I; Mikelsaar R-H; Mikelsaar M; Verrips T; Hammarstrom L; Marcotte H
Article: PLOS ONE. 2016;11(9):e0162733
Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats
Lin Y; Krogh-Andersen K; Pelletier J; Marcotte H; Ostenson C-G; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2015;81(17):5784-5793
An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface
Alvarez B; Krogh-Andersen K; Tellgren-Roth C; Martinez N; Guenaydin G; Lin Y; Cruz Martin M; Alvarez MA; Hammarstroem L; Marcotte H
Article: BMC INFECTIOUS DISEASES. 2015;15:255
Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection
Pendharkar S; Brandsborg E; Hammarstrom L; Marcotte H; Larsson P-G
Article: VACCINE. 2014;32(4):470-477
Engineered Lactobacillus rhamnosus GG expressing IgG-binding domains of protein G: Capture of hyperimmune bovine colostrum antibodies and protection against diarrhea in a mouse pup rotavirus infection model
Gunaydin G; Zhang R; Hammarstroem L; Marcotte H
Article: PLOS ONE. 2014;9(4):e96409
Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem
Gunaydin G; Alvarez B; Lin Y; Hammarstroem L; Marcotte H
Article: JOURNAL OF CLINICAL INVESTIGATION. 2013;123(9):3829-3838
Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection
Tokuhara D; Alvarez B; Mejima M; Hiroiwa T; Takahashi Y; Kurokawa S; Kuroda M; Oyama M; Kozuka-Hata H; Nochi T; Sagara H; Aladin F; Marcotte H; Frenken LGJ; Iturriza-Gomara M; Kiyono H; Hammarstrom L; Yuki Y
Article: BMC INFECTIOUS DISEASES. 2013;13:43
Identification and characterisation of vaginal lactobacilli from South African women
Pendharkar S; Magopane T; Larsson P-G; de Bruyn G; Gray GE; Hammarstrom L; Marcotte H
Article: BMC BIOTECHNOLOGY. 2011;11:126
In situ gastrointestinal protection against anthrax edema toxin by single-chain antibody fragment producing lactobacilli
Andersen KK; Marcotte H; Alvarez B; Boyaka PN; Hammarstrom L
Article: BMC INFECTIOUS DISEASES. 2011;11:223
Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses
Larsson P-G; Brandsborg E; Forsum U; Pendharkar S; Andersen KK; Nasic S; Hammarstrom L; Marcotte H
Article: FUTURE MICROBIOLOGY. 2011;6(5):583-593
Lactobacilli producing bispecific llama-derived anti-rotavirus proteins in vivo for rotavirus-induced diarrhea
Pant N; Marcotte H; Hermans P; Bezemer S; Frenken L; Johansen K; Hammarstrom L
Article: APPLIED AND ENVIRONMENTAL MICROBIOLOGY. 2011;77(6):2174-2179
Integrative Expression System for Delivery of Antibody Fragments by Lactobacilli
Cruz Martin M; Pant N; Ladero V; Gunaydin G; Andersen KK; Alvarez B; Martinez N; Alvarez MA; Hammarstrom L; Marcotte H
Article: CURRENT MICROBIOLOGY. 2010;61(6):560-566
Screening and Evaluation of Human Intestinal Lactobacilli for the Development of Novel Gastrointestinal Probiotics
Koll P; Maendar R; Smidt I; Huett P; Truusalu K; Mikelsaar R-H; Shchepetova J; Krogh-Andersen K; Marcotte H; Hammarstrom L; Mikelsaar M
Article: FUTURE VIROLOGY. 2008;3(4):327-341
Engineered lactobody-producing lactobacilli:: a novel form of therapy against rotavirus infection
Marcotte H; Pant N; Hammarstrom L
Article: MOLECULAR ORAL MICROBIOLOGY. 2008;23(2):139-147
Characterization of oral lactobacilli as potential probiotics for oral health
Koll P; Maendar R; Marcotte H; Leibur E; Mikelsaar M; Hammarstro L
Article: BMC MICROBIOLOGY. 2007;7:86
Effective prophylaxis against rotavirus diarrhea using a combination of Lactobacillus rhamnosus GG and antibodies
Pant N; Marcotte H; Bruessow H; Svensson L; Hammarstrom L
Article: BMC BIOTECHNOLOGY. 2007;7:58
Lactobacillli expressing llama VHH fragments neutralise Lactococcus phages
Hultberg A; Tremblay DM; de Haard H; Verrips T; Moineau S; Hammarstoem L; Marcotte H
Article: JOURNAL OF INFECTIOUS DISEASES. 2006;194(11):1580-1588
Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea
Pant N; Hultberg A; Zhao Y; Svensson L; Pan-Hammarstrom Q; Johansen K; Pouwels PH; Ruggeri FM; Hermans P; Frenken L; Boren T; Marcotte H; Hammarstrom L
Article: APPLIED MICROBIOLOGY AND BIOTECHNOLOGY. 2006;72(4):732-737
Therapeutic effect of llama derived VHH fragments against Streptococcus mutans on the development of dental caries
Kruger C; Hultberg A; Marcotte H; Hermans P; Bezemer S; Frenken LGJ; Hammarstrom L
Article: JOURNAL OF APPLIED MICROBIOLOGY. 2006;100(2):256-263
Expression of single-chain antibody against RgpA protease of Porphyromonas gingivalis in Lactobacillus
Marcotte H; Koll-Klais P; Hultberg A; Zhao Y; Gmür R; Mändar R; Mikelsaar M; Hammarström L
Article: MOLECULAR ORAL MICROBIOLOGY. 2005;20(6):354-361
Oral lactobacilli in chronic periodontitis and periodontal health:: species composition and antimicrobial activity
Koll-Klais P; Mändar R; Leibur E; Marcotte H; Hammarström L; Mikelsaar M
Article: MOLECULAR BIOTECHNOLOGY. 2005;31(3):221-231
Passive immunization by lactobacilli expressing single-chain antibodies against Streptococcus mutans
Krüger C; Hultberg A; van Dollenweerd C; Marcotte H; Hammarström L
Article: INFECTION AND IMMUNITY. 2004;72(5):2753-2761
Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C.
Robinson K; Chamberlain LM; Lopez MC; Rush CM; Marcotte H; Le Page RWF; Wells JM
Article: JOURNAL OF APPLIED MICROBIOLOGY. 2004;97(4):749-756
The aggregation-promoting factor of Lactobacillus crispatus M247 and its genetic locus
Marcotte H; Ferrari S; Cesena C; Hammarström L; Morelli L; Pozzi G; Oggioni MR
Article: NATURE BIOTECHNOLOGY. 2002;20(7):702-706
In situ delivery of passive immunity by lactobacilli producing single-chain antibodies
Krüger C; Hu YZ; Pan Q; Marcotte H; Hultberg A; Delwar D; van Dalen PJ; Pouwels PH; Leer RJ; Kelly CG; van Dollenweerd C; Ma JK; Hammarström L
Article: MICROBIAL PATHOGENESIS. 2001;30(4):229-235
Immunoglobulin-binding domains of peptostreptococcal protein L enhance vaginal colonization of mice by Streptococcus gordonii.
Ricci S; Medaglini D; Marcotte H; Olsén A; Pozzi G; Björck L
Article: VACCINE. 2001;19(15-16):1931-1939
Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Article: MOLECULAR ORAL MICROBIOLOGY. 1997;12(3):141-147
Comparison of the indigenous oral microbiota and immunoglobulin responses of athymic (nu/nu) and euthymic (nu/+) mice.
Marcotte H; Lavoie MC
Article: INFECTION AND IMMUNITY. 1996;64(11):4694-4699
No apparent influence of immunoglobulins on indigenous oral and intestinal microbiota of mice.
Marcotte H; Lavoie MC
Article: JOURNAL OF INFECTIOUS DISEASES. 1996;173(4):1034-1037
Pneumocystis carinii infection in transgenic B cell-deficient mice.
Marcotte H; Levesque D; Delanay K; Bourgeault A; de la Durantaye R; Brochu S; Lavoie MC
Article: MOLECULAR ORAL MICROBIOLOGY. 1995;10(3):168-174
Colonization of the oral cavity of mice by an unidentified streptococcus.
Marcotte H; Rodrigue L; Coulombe C; Goyette N; Lavoie MC
Article: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY. 1995;371B:1173-1176
Immunization against the oral indigenous bacteria of the BALB/c mouse.
Marcotte H; Rodrigue L; Gamache M; Lavoie MC
Journal article: JOURNAL OF IMMUNOASSAY. 1993;14(1-2):63-81
Evaluation of mouse salivary IgA directed against indigenous oral bacteria.
Marcotte H; Lavoie MC
Show more

All other publications

Editorial comment: THE LANCET INFECTIOUS DISEASES. 2024;24(1):e7-e9
Neutralisation activity of mucosal IgA against XBB sublineages and BA.2.86
Zuo F; Cao Y; Sun R; Yisimayi A; Du L; Bertoglio F; Schubert M; Guerra C; Cavalli A; Hust M; Robbiani DF; Abolhassani H; Xie XS; Hammarstroem L; Marcotte H; Pan-Hammarstroem Q
Letter: THE LANCET REGIONAL HEALTH. WESTERN PACIFIC. 2023;33:100762
Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1
Zuo F; Sun R; Abolhassani H; Du L; Wang Y; Vlachiotis S; Bertoglio F; Schubert M; Rezaei N; Chavoshzadeh Z; Guerra C; Cavalli A; Andrell J; Kumagai-Braesch M; Xue Y; Cao Y; Hust M; Robbiani DF; Xie XS; Hammarstrom L; Marcotte H; Pan-Hammarstrom Q
Preprint: BIORXIV. 2022;BIORXIV
Human neutralizing antibodies to cold linear epitopes and to subdomain 1 of SARS-CoV-2.
Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Rincón TC; Fava T; Podešvová L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Hönig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Ciabattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarström Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
Letter: NEW ENGLAND JOURNAL OF MEDICINE. 2022;387(21):e55
Mucosal IgA against SARS-CoV-2 Omicron Infection
Zuo F; Marcotte H; Hammarstrom L; Pan-Hammarstrom Q
Editorial comment: SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2022;7(1):294
Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster
Marcotte H; Hammarstrom L; Pan-Hammarstrom Q
Review: CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY. 2021;21(6):553-558
Antibody therapy for COVID-19
Hammarstrom L; Marcotte H; Piralla A; Baldanti F; Pan-Hammarstrom Q
Review: CURRENT OPINION IN BIOTECHNOLOGY. 2021;70:75-82
Advancing mechanistic understanding and bioengineering of probiotic lactobacilli and bifidobacteria by genome editing
Zuo F; Marcotte H
Review: BIOTECHNOLOGY ADVANCES. 2020;45:107654
Engineer probiotic bifidobacteria for food and biomedical applications - Current status and future prospective
Zuo F; Chen S; Marcotte H
Editorial comment: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2020;146(1):58-60
Development of passive immunity against SARS-CoV-2 for management of immunodeficient patients-a perspective
Hammarstrom L; Abolhassani H; Baldanti F; Marcotte H; Pan-Hammarstrom Q
Review: CURRENT MICROBIOLOGY. 2019;76(6):774-782
Clostridium difficile, the Difficult "Kloster" Fuelled by Antibiotics
Dicks LMT; Mikkelsen LS; Brandsborg E; Marcotte H
Review: BENEFICIAL MICROBES. 2018;9(1):3-20
Our gut microbiota: a long walk to homeostasis
Dicks LMT; Geldenhuys J; Mikkelsen LS; Brandsborg E; Marcotte H
Book chapter: VIRAL GASTROENTERITIS. 2016;p. 47-71
Chapter 1.3 Immunodeficiencies: Significance for Gastrointestinal Disease
Marcotte H; Hammarström L
Book chapter: MUCOSAL IMMUNOLOGY. 2015;p. 1403-1434
Chapter 71 Passive Immunization Toward Magic Bullets
Marcotte H; Hammarström L
Published conference paper: BENEFICIAL MICROBES. 2011;2(1):79-90
Safety and persistence of orally administered human Lactobacillus sp strains in healthy adults
Huett P; Koll P; Stsepetova J; Alvarez B; Maendar R; Krogh-Andersen K; Marcotte H; Hammarstroem L; Mikelsaar M
Review: MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS. 1998;62(1):71-109
Oral microbial ecology and the role of salivary immunoglobulin A.
Marcotte H; Lavoie MC

Employments

Researcher, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 2023-

Degrees and Education

Docent, Karolinska Institutet, 2018

About me

Teaching

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI